Lipid profile components and subclinical cerebrovascular disease in the northern manhattan study

Cerebrovascular Diseases

Volumn 37, Issue 6, 2014, Pages 423-430

  Willey, Joshua Z ^a   Gardener, Hannah ^c   Moon, Yeseon P ^a   Yoshita, Mitsuhiro ^e   DeCarli, Charles ^d   Cheung, Ying Kuen ^b   Sacco, Ralph L ^c   Elkind, Mitchell S V ^a,b   Wright, Clinton B ^c  

^a NEUROLOGICAL INSTITUTE   (United States)

^b Department of Biostatistics Columbia University ^*  (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e National Hospital Organization   (Japan)

Author keywords

Plasma lipids; Risk Factors; Silent Infarct; White Matter

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; APOLIPOPROTEIN E4; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLACK PERSON; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CAUCASIAN; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; GENOTYPE; HISPANIC; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; WHITE MATTER HYPERINTENSITY VOLUME; HIGH RISK PATIENT; LOW RISK PATIENT; PREVALENCE; WHITE MATTER; AGED; AGING; BLOOD; GENETICS; LIPID METABOLISM; STROKE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEINS E; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; LIPID METABOLISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84904272537     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000362920     Document Type: Article

References (40)

1. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, Romero JR, Kase CS, Wolf PA, Seshadri S: Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010; 41: 600-606.
2. LADIS Study Group: 2001-2011: a decade of the LADIS (Leukoaraiosis And DISability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 2011; 32: 577-588.
3. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995; 346: 1647-1653.
4. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP: Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 1994; 49:M252-M257.
5. Byington RP, Davis BR, Plehn JF, White HD, Baker J, Cobbe SM, Shepherd J: Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation 2001; 103: 387-392.
6. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, et al: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-559.
7. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM: Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004; 63: 1868-1875.
8. Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA: Venous collagenosis and arteriolar tortuosity in leukoaraiosis. J Neurol Sci 2002; 203-204: 159-163.
9. Willey JZ, Moon YP, Paik MC, Yoshita M, Decarli C, Sacco RL, Elkind MS, Wright CB: Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study. Neurology 2011; 76: 2112-2118.
10. Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S, Massasa E, Cloonan L, Gilson A, Capozzo K, et al: Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 2010; 41: 437-442.
11. Mahley RW, Rall SC Jr: Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507-537.
12. Prabhakaran S, Wright CB, Yoshita M, Delapaz R, Brown T, DeCarli C, Sacco RL: Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology 2008; 70: 425-430.
13. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC: Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke 2004; 35: 2263-2269.
14. Paultre F, Tuck CH, Boden-Albala B, Kargman DE, Todd E, Jones J, Paik MC, Sacco RL, Berglund L: Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol 2002; 22: 141-146.
15. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Nordestgaard BG, Benn M: Fasting and nonfasting LDL cholesterol: to measure or calculate? Clin Chem 2009; 55: 845-847.
17. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
18. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Garner J, Jack L, Carmelli D: Predictors of brain morphology for the men of the NHLBI twin study. Stroke 1999; 30: 529-536.
19. DeCarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA, Salerno JA, Gonzales- Aviles A, Horwitz B, Rapoport SI, et al: The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995; 45: 2077-2084.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
21. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C, Hirsch CH, O'Leary DH, Furberg CD: Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005; 36: 56-61.
22. Ichikawa H, Mukai M, Ohno H, Shimizu Y, Itaya K, Kawamura M: Deep white matter hyperintensities, decreased serum low-density lipoprotein, and dilative large arteriopathy. J Stroke Cerebrovasc Dis 2012; 21: 225-230.
23. Paternoster L, Chen W, Sudlow CL: Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. Stroke 2009; 40: 2020-2026.
24. Willey JZ, Xu Q, Boden-Albala B, Paik MC, Moon YP, Sacco RL, Elkind MS: Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol 2009; 66: 1400-1406.
25. Bezerra DC, Sharrett AR, Matsushita K, Gottesman RF, Shibata D, Mosley TH Jr, Coresh J, Szklo M, Carvalho MS, Selvin E: Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology 2012; 78: 102-108.
26. Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ: Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008; 131: 3286-3298.
27. Martini SR, Flaherty ML, Brown WM, Haverbusch M, Comeau ME, Sauerbeck LR, Kissela BM, Deka R, Kleindorfer DO, Moomaw CJ, et al: Risk factors for intracerebral hemorrhage differ according to hemorrhage location. Neurology 2012; 79: 2275-2282.
28. Messe SR, Pervez MA, Smith EE, Siddique KA, Hellkamp AS, Saver JL, Bhatt DL, Fonarow GC, Peterson ED, Schwamm LH: Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in Get With the Guidelines-Stroke. Stroke 2013; 44: 1354-1359.
29. D'Amelio M, Terruso V, Famoso G, Ragonese P, Aridon P, Savettieri G: Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke. Cerebrovasc Dis 2011; 32: 234-238.
30. Chen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, Greenberg SM, Smith EE: Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 2006; 67: 83-87.
31. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW: CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354-1357.
32. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, Sharrett AR: Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003; 34: 623-631.
33. Psaty BM, Anderson M, Kronmal RA, Tracy RP, Orchard T, Fried LP, Lumley T, Robbins J, Burke G, Newman AB, et al: The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc 2004; 52: 1639-1647.
34. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385-390.
35. Boden-Albala B, Sacco RL, Lee HS, Grahame- Clarke C, Rundek T, Elkind MV, Wright C, Giardina EG, DiTullio MR, Homma S, et al: Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 2008; 39: 30-35.
36. Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A: Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb Vasc Biol 2012; 32: 2060-2067.
37. Rost NS, Rahman R, Sonni S, Kanakis A, Butler C, Massasa E, Cloonan L, Gilson A, Delgado P, Chang Y, et al: Determinants of white matter hyperintensity volume in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 2010; 19: 230-235.
38. Mok VC, Lam WW, Fan YH, Wong A, Ng PW, Tsoi TH, Yeung V, Wong KS: Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol 2009; 256: 750-757.
39. ten Dam VH, van den Heuvel DM, van Buchem MA, Westendorp RG, Bollen EL, Ford I, de Craen AJ, Blauw GJ: Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 2005; 64: 1807-1809.
40. Fu JH, Mok V, Lam W, Wong A, Chu W, Xiong Y, Ng PW, Tsoi TH, Yeung V, Wong KS: Effects of statins on progression of subclinical brain infarct. Cerebrovasc Dis 2010; 30: 51-56. Stroke